Get started
Author

Francesco Verderame

Observed names: F VERDERAME, F Verderame, F. VERDERAME, F. Verderame, FRANCESCO VERDERAME, Verderame, Francesco
Observed institutions: University of Cagliari, Casa Sollievo della Sofferenza, IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola, Ospedale Vincenzo Cervello, Azienda Ospedaliero-Universitaria delle Marche, Lega Italiana per la Lotta ai Tumori, Fondazione Istituto G. Giglio di Cefalù, Ospedale Policlinico San Martino, Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo, Ospedale Vito Fazzi, Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo, Azienda Ospedaliera Treviglio, University of Palermo, University of Bologna
ORCID: 0000-0001-5746-2845
Observed ORCID: 0000-0001-5746-2845
OpenAlex ID: A5075338390
Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
2019 · Luis Paz-Ares, Mikhail Dvorkin, et al. · The Lancet · 2,281
Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial
2020 · Jonathan W Goldman, Mikhail Dvorkin, et al. · The Lancet Oncology · 688
Treatment of Inoperable and/or Metastatic Biliary Tree Carcinomas With Single-Agent Gemcitabine or in Combination With Levofolinic Acid and Infusional Fluorouracil: Results of a Multicenter Phase II Study
2001 · Vittorio Gebbia, Francesco Giuliani, et al. · Journal of Clinical Oncology · 141
Real-world efficacy and safety of lenvatinib: data from a compassionate use in the treatment of radioactive iodine-refractory differentiated thyroid cancer patients in Italy
2019 · L.D. Locati, A. Piovesan, et al. · European Journal of Cancer · 98
Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial
2019 · Ignace Vergote, Giovanni Scambia, et al. · The Lancet Oncology · 87
PDF
Clinical Outcomes of Castration-resistant Prostate Cancer Treatments Administered as Third or Fourth Line Following Failure of Docetaxel and Other Second-line Treatment: Results of an Italian Multicentre Study
2014 · Orazio Caffo, Ugo De Giorgi, et al. · European Urology · 83
Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours
2023 · Ciro Celsa, Giuseppe Cabibbo, et al. · Journal of Hepatology · 71
PDF
Gemcitabine and oxaliplatin combination chemotherapy in advanced biliary tract cancers
2006 · F. Verderame, A. Russo, et al. · Annals of Oncology · 55
Second-line chemotherapy in advanced pancreatic carcinoma: a multicenter survey of the Gruppo Oncologico Italia Meridionale on the activity and safety of the FOLFOX4 regimen in clinical practice
2007 · V. Gebbia, E. Maiello, et al. · Annals of Oncology · 53
Impact of Brain Metastases on Treatment Patterns and Outcomes With First-Line Durvalumab Plus Platinum-Etoposide in Extensive-Stage SCLC (CASPIAN): A Brief Report
2022 · Yuanbin Chen, Luis Paz-Ares, et al. · JTO Clinical and Research Reports · 48
PDF
Durvalumab ± tremelimumab + platinum-etoposide in first-line extensive-stage SCLC (ES-SCLC): Updated results from the phase III CASPIAN study.
2020 · Luis G. Paz-Ares, Mikhail Dvorkin, et al. · Journal of Clinical Oncology · 48
Immune-related adverse events correlate with clinical outcomes in NSCLC patients treated with nivolumab: The Italian NSCLC expanded access program
2019 · Editta Baldini, Alice Lunghi, et al. · Lung Cancer · 43
‘My wig has been my journey's companion’: perceived effects of an aesthetic care programme for Italian women suffering from chemotherapy-induced alopecia
2012 · L. ZANNINI, F. VERDERAME, et al. · European Journal of Cancer Care · 42
Virtual Multidisciplinary Tumor Boards: A Narrative Review Focused on Lung Cancer
2021 · Vittorio Gebbia, Aurelia Guarini, et al. · Pulmonary Therapy · 41
PDF
Efficacy of Pennebaker’s expressive writing intervention in reducing psychiatric symptoms among patients with first-time cancer diagnosis: a randomized clinical trial
2018 · Luana La Marca, Erika Maniscalco, et al. · Supportive Care in Cancer · 37
Efficacy and Safety of Cetuximab/Irinotecan in Chemotherapy-Refractory Metastatic Colorectal Adenocarcinomas: A Clinical Practice Setting, Multicenter Experience
2006 · Vittorio Gebbia, Salvatore Del Prete, et al. · Clinical Colorectal Cancer · 37
Italian Cohort of the Nivolumab EAP in Squamous NSCLC: Efficacy and Safety in Patients With CNS Metastases
2019 · DIEGO CORTINOVIS, RITA CHIARI, et al. · Anticancer Research · 36
PDF
Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: A prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale)
2008 · Vittorio Gebbia, Domenico Galetta, et al. · Lung Cancer · 35
Vinorelbine plus cisplatinum for the treatment of stage IIIB and IV non small cell lung carcinoma.
1994 · V Gebbia, M Caruso, et al. · PubMed · 30
Using peripheral immune-inflammatory blood markers in tumors treated with immune checkpoint inhibitors: An INVIDIa-2 study sub-analysis
2023 · Shobana Anpalakhan, Alessio Signori, et al. · iScience · 28
PDF
Liposomal-encapsulated doxorubicin plus cyclophosphamide as first-line therapy in metastatic breast cancer: a phase II multicentric study
2007 · F. Giotta, V. Lorusso, et al. · Annals of Oncology · 28
Biliary tract cancer: our experience with gemcitabine treatment
2000 · Francesco Verderame, Pietro Mandina, et al. · Anti-Cancer Drugs · 28
Hypo-fractionated stereotactic radiation therapy for lung malignancies by means of helical tomotherapy: report of feasibility by a single-center experience
2018 · Vanessa Figlia, Rosario Mazzola, et al. · La radiologia medica · 27
Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG
2020 · Melissa Bersanelli, Diana Giannarelli, et al. · Therapeutic Advances in Medical Oncology · 25
INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a multicenter prospective observational study (INVIDIa-2)
2021 · Melissa Bersanelli, Diana Giannarelli, et al. · Journal for ImmunoTherapy of Cancer · 23
PDF
Works count: 137
Citation count: 7,553
H-index: 25
I10-index: 47
Year
Topic
Type